BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33594224)

  • 1. Extracellular vesicle concentrations of glial fibrillary acidic protein and neurofilament light measured 1 year after traumatic brain injury.
    Flynn S; Leete J; Shahim P; Pattinson C; Guedes VA; Lai C; Devoto C; Qu BX; Greer K; Moore B; van der Merwe A; Ekanayake V; Gill J; Chan L
    Sci Rep; 2021 Feb; 11(1):3896. PubMed ID: 33594224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI.
    Shahim P; Politis A; van der Merwe A; Moore B; Ekanayake V; Lippa SM; Chou YY; Pham DL; Butman JA; Diaz-Arrastia R; Zetterberg H; Blennow K; Gill JM; Brody DL; Chan L
    Neurology; 2020 Aug; 95(6):e623-e636. PubMed ID: 32641529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial fibrillary acidic protein elevations relate to neuroimaging abnormalities after mild TBI.
    Gill J; Latour L; Diaz-Arrastia R; Motamedi V; Turtzo C; Shahim P; Mondello S; DeVoto C; Veras E; Hanlon D; Song L; Jeromin A
    Neurology; 2018 Oct; 91(15):e1385-e1389. PubMed ID: 30209234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Tau, Neurofilament Light Chain, Glial Fibrillary Acidic Protein, and Ubiquitin Carboxyl-Terminal Hydrolase L1 Are Associated with the Chronic Deterioration of Neurobehavioral Symptoms after Traumatic Brain Injury.
    Lange RT; Lippa S; Brickell TA; Gill J; French LM
    J Neurotrauma; 2023 Mar; 40(5-6):482-492. PubMed ID: 36170576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical descriptors of disease trajectories in patients with traumatic brain injury in the intensive care unit (CENTER-TBI): a multicentre observational cohort study.
    Åkerlund CAI; Holst A; Bhattacharyay S; Stocchetti N; Steyerberg E; Smielewski P; Menon DK; Ercole A; Nelson DW;
    Lancet Neurol; 2024 Jan; 23(1):71-80. PubMed ID: 37977157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of neurofilament-H in serum as a diagnostic tool to predict injury severity in patients who have suffered mild traumatic brain injury.
    Gatson JW; Barillas J; Hynan LS; Diaz-Arrastia R; Wolf SE; Minei JP
    J Neurosurg; 2014 Nov; 121(5):1232-8. PubMed ID: 25192482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma extracellular vesicles as a source of biomarkers in traumatic brain injury.
    Puffer RC; Cumba Garcia LM; Himes BT; Jung MY; Meyer FB; Okonkwo DO; Parney IF
    J Neurosurg; 2020 Jul; 134(6):1921-1928. PubMed ID: 32707544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury.
    Andersson E; Öst M; Dalla K; Zetterberg H; Blennow K; Nellgård B
    Neurocrit Care; 2024 May; ():. PubMed ID: 38769253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicle neurofilament light is elevated within the first 12-months following traumatic brain injury in a U.S military population.
    Guedes VA; Lange RT; Lippa SM; Lai C; Greer K; Mithani S; Devoto C; A Edwards K; Wagner CL; Martin CA; Driscoll AE; Wright MM; Gillow KC; Baschenis SM; Brickell TA; French LM; Gill JM
    Sci Rep; 2022 Mar; 12(1):4002. PubMed ID: 35256615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-acute blood biomarkers and disease progression in traumatic brain injury.
    Newcombe VFJ; Ashton NJ; Posti JP; Glocker B; Manktelow A; Chatfield DA; Winzeck S; Needham E; Correia MM; Williams GB; Simrén J; Takala RSK; Katila AJ; Maanpää HR; Tallus J; Frantzén J; Blennow K; Tenovuo O; Zetterberg H; Menon DK
    Brain; 2022 Jun; 145(6):2064-2076. PubMed ID: 35377407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood biomarkers of traumatic brain injury and cognitive impairment in older veterans.
    Peltz CB; Kenney K; Gill J; Diaz-Arrastia R; Gardner RC; Yaffe K
    Neurology; 2020 Sep; 95(9):e1126-e1133. PubMed ID: 32571850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI study.
    Czeiter E; Amrein K; Gravesteijn BY; Lecky F; Menon DK; Mondello S; Newcombe VFJ; Richter S; Steyerberg EW; Vyvere TV; Verheyden J; Xu H; Yang Z; Maas AIR; Wang KKW; Büki A;
    EBioMedicine; 2020 Jun; 56():102785. PubMed ID: 32464528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Levels of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 During the First Week After a Traumatic Brain Injury: Correlations With Clinical and Imaging Findings.
    Posti JP; Takala RS; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Coles JP; Hossain MI; Kyllönen A; Maanpää HR; Tallus J; Hutchinson PJ; van Gils M; Menon DK; Tenovuo O
    Neurosurgery; 2016 Sep; 79(3):456-64. PubMed ID: 26963330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 as Outcome Predictors in Traumatic Brain Injury.
    Takala RS; Posti JP; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Kyllönen A; Maanpää HR; Tallus J; Hossain MI; Coles JP; Hutchinson P; van Gils M; Menon DK; Tenovuo O
    World Neurosurg; 2016 Mar; 87():8-20. PubMed ID: 26547005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increases of Plasma Levels of Glial Fibrillary Acidic Protein, Tau, and Amyloid β up to 90 Days after Traumatic Brain Injury.
    Bogoslovsky T; Wilson D; Chen Y; Hanlon D; Gill J; Jeromin A; Song L; Moore C; Gong Y; Kenney K; Diaz-Arrastia R
    J Neurotrauma; 2017 Jan; 34(1):66-73. PubMed ID: 27312416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial Measurements of Serum Glial Fibrillary Acidic Protein in Moderate-Severe Traumatic Brain Injury: Potential Utility in Providing Insights into Secondary Insults and Long-Term Outcome.
    Robertson CS; Martinez FS; McQuillan LE; Williamson J; Lamb DG; Wang KKW; Rubenstein R; Wagner AK
    J Neurotrauma; 2024 Jan; 41(1-2):73-90. PubMed ID: 37489296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Levels of Glial Fibrillary Acidic Protein and Neurofilament Light Protein in Predicting the Outcome of Mild Traumatic Brain Injury.
    Hossain I; Mohammadian M; Takala RSK; Tenovuo O; Lagerstedt L; Ala-Seppälä H; Frantzén J; van Gils M; Hutchinson P; Katila AJ; Maanpää HR; Menon DK; Newcombe VF; Tallus J; Hrusovsky K; Wilson DH; Blennow K; Sanchez JC; Zetterberg H; Posti JP
    J Neurotrauma; 2019 May; 36(10):1551-1560. PubMed ID: 30489229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular Vesicle Levels of Nervous System Injury Biomarkers in Critically Ill Trauma Patients with and without Traumatic Brain Injury.
    Guedes VA; Mithani S; Williams C; Sass D; Smith EG; Vorn R; Wagner C; Lai C; Gill J; Hinson HE
    Neurotrauma Rep; 2022; 3(1):545-553. PubMed ID: 36636744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Admission levels of serum biomarkers have additive and cumulative prognostic value in traumatic brain injury.
    Kaaber IA; Lesbo M; Wichmann TO; Olsen DA; Rasmussen MM; Brink O; Borris LC; Hviid CVB
    Sci Rep; 2024 Jun; 14(1):14139. PubMed ID: 38898030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Neurofilament Light and Glial Fibrillary Acidic Protein Levels over Thirty Days in a Porcine Model of Traumatic Brain Injury.
    Shin SS; Hefti MM; Mazandi VM; Issadore DA; Meaney DF; Schneider ALC; Diaz-Arrastia R; Kilbaugh TJ
    J Neurotrauma; 2022 Jul; 39(13-14):935-943. PubMed ID: 35369719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.